MedPath

Fomepizole

Fomepizole Injection

Approved
Approval ID

911312e2-3a7c-4c97-88a8-b8d92cd12923

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fomepizole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-211
Application NumberANDA078639
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fomepizole
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 15, 2018
FDA Product Classification

INGREDIENTS (1)

FomepizoleActive
Quantity: 1 g in 1 mL
Code: 83LCM6L2BY
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fomepizole - FDA Drug Approval Details